Evrofarma SA (ATH: EVROF)

Evrofarma Revenue

Evrofarma had revenue of 21.65M EUR in the half year ending June 30, 2024, with 9.90% growth. This brings the company's revenue in the last twelve months to 46.84M, down -4.88% year-over-year. In the year 2023, Evrofarma had annual revenue of 48.76M with 7.45% growth.

• Revenue (ttm): 46.84M
• Revenue Growth: -4.88%
• P/S Ratio: 0.52
• Revenue / Employee: 282.19K
• Employees: 156
• Market Cap: 24.54M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	48.76M	3.38M	7.45%
Dec 31, 2022	45.38M	8.68M	23.66%
Dec 31, 2021	36.70M	2.79M	8.23%
Dec 31, 2020	33.91M	429.00K	1.28%
Dec 31, 2019	33.48M	945.00K	2.90%